Press Release

United States flu vaccine market is expected to reach nearly US$ 3 Billion by 2024. Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine.

Download Sample of This Strategic Report:-https://www.kennethresearch.com/sample-request-10077099

“Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024” provides a deep and thorough evaluation of the United States flu vaccine market. The report provides an in–depth analysis of the flu vaccination pattern in both Children and Adults in the United States. It also provides essential insights into flu vaccine production, price, consumption, supply, distribution, demand and specification. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and promising flu vaccines in the clinical development. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

Long–term Growth Projection and Development:

• Sanofi to Acquire Protein Sciences Corporation
• It is likely that more than 185 Million persons being vaccinated with flu vaccines in 2024.
• Nearly 160 Million doses of flu vaccines have shipped to US for the 2017-2018 flu season
• It is projected that GSK flu vaccine sales value will reach around US$ 1.5 Billion by 2024
• BiondVax reports positive phase 2b clinical trial results for its universal flu vaccine

Request For Full Report >> https://www.kennethresearch.com/sample-request-10077099

The report concludes with the profiles of major players in the US flu vaccine market such as Sanofi Pasteur, GSK and Seqirus. The major market players are evaluated on various parameters such as company overview, product outlook, latest development & trends and sales analysis of flu vaccine market from 2011 to 2022. The report also entails major drivers and inhibitors in the US flu vaccine market.

Key Topics Covered in the Report

• Market Overview: United States Flu Vaccine Market (2010 – 2024)
• United States Number of Persons Vaccinated with Flu Vaccine (2010 – 2024)
• United States Flu Vaccine Production, Price, Consumption, Supply, Distribution, Demand and Specification
• Reimbursement & Regulatory System in the US Flu Vaccine Market
• Mergers, Acquisitions, Key Agreements & Collaborations
• Promising Flu Vaccine in Clinical Development
• Flu Vaccine Clinical Trial Insights by Phase, Company & Country
• Key Drivers and Inhibitors of the US Flu Vaccine Market
• Key Companies Analysis

Major Flu Vaccines Covered Under This Report Are:

• Fluzone High–Dose
• Fluzone Quadrivalent
• Intradermal (ID) Trivalent
• Vaxigrip
• Fluarix Quadrivalent
• Flulaval Quadrivalent
• Flucelvax Quadrivalent
• Afluria Quadrivalent
• Agrippal
• Fluad
• Fluvirin
• FluvaxRequest

Request For Full Report >> https://www.kennethresearch.com/sample-request-10077099

Key Companies Covered in This Report:

• Seqirus
• Sanofi Pasteur
• GlaxoSmithKline(GSK)

1. Executive Summary

2. Market Overview: United States Flu Vaccine Market (2010 – 2024)

3. United States Number of Persons Vaccinated with Flu Vaccine (2010 – 2024)
3.1 Number of Children Vaccinated
3.2 Number of Adults Vaccinated

4. Key Drivers and Inhibitors of the United States Flu Vaccine Market
4.1 Market Drivers
4.2 Market Inhibitors

5. United States Flu Vaccine Production, Price, Consumption, Supply, Distribution, Demand and Specification
5.1 Flu Vaccine Price Trends
5.1.1 Pediatric Flu Vaccine Price Trends
5.1.2 Adult Flu Vaccine Price Trends
5.2 United States Flu Vaccine Production, Supply, and Allocation (By Companies)
5.3 United States Flu Vaccine Distribution & Demand
5.4 Flu Vaccine Effectiveness
5.5 Managing Flu with Rapid Diagnostic Testing
5.6 Distribution Method of Flu Vaccination

 

About Us

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us
Name: Kenneth research
Email:[email protected]
Phone: +1 313 462 0609

Other Report:

China Outbound MICE Market

United States Flu Vaccine Market share, United States Flu Vaccine Market analysis, United States Flu Vaccine Market Forecast, United States Flu Vaccine Market Trend, United States Flu Vaccine Market Prediction, United States Flu Vaccine Market Demand, United States Flu Vaccine Market Size,  United States Flu Vaccine Market Status

Source : United States Flu Vaccine Market Study | Key Players are Seqirus, Sanofi Pasteur and GlaxoSmithKline(GSK)

This post was originally published on The Picayune Current